# Lingraphicare America, Inc. – FDA Inspection, Feb 3, 2025

Source: https://www.keypedia.com/records/fda_inspections/lingraphicare-america-inc/bfb10226-9c1d-4dd0-b23d-bf3d1a8463bb
Source feed: FDA_Inspections

> FDA inspection 1261187 of Lingraphicare America, Inc., February 03, 2025. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR parts 803 and 820. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261187
- Company Name: Lingraphicare America, Inc.
- Inspection Date: 2025-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Compliance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: New Jersey District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1177262 - 2022-08-04](https://www.keypedia.com/records/fda_inspections/lingraphicare-america-inc/90752a9d-7a12-4264-bf1f-d38d45b7fd6b)
- FDA Inspection 1109991 - 2019-11-15
- [FDA Inspection 1002305 - 2017-02-15](https://www.keypedia.com/records/fda_inspections/lingraphicare-america-inc/c0c4ea2f-122a-4fa2-8c7e-69e0f779a11e)
- FDA Inspection 883463 - 2014-06-24
- FDA Inspection 759639 - 2011-12-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/frank-j-marciniak/6995351a-6afc-4056-9692-d4aeb711dd92)

Company: https://www.keypedia.com/companies/lingraphicare-america-inc/4f47f1e2-0d44-4ffa-8f31-79fdb892b071

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
